Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101023673 | 10102367 | 3 | F | 20131105 | 20160706 | 20140424 | 20160713 | EXP | PHHY2013IE126927 | NOVARTIS | 43.01 | YR | F | Y | 0.00000 | 20160714 | CN | COUNTRY NOT SPECIFIED | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101023673 | 10102367 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 64 | MG | 22527 | .5 | MG | CAPSULE | QD | ||||
| 101023673 | 10102367 | 2 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 64 | MG | 22527 | .5 | MG | CAPSULE | QD | ||||
| 101023673 | 10102367 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
| 101023673 | 10102367 | 4 | C | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 101023673 | 10102367 | 5 | C | TETRACYCLINE | TETRACYCLINE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101023673 | 10102367 | 1 | Relapsing-remitting multiple sclerosis |
| 101023673 | 10102367 | 3 | Product used for unknown indication |
| 101023673 | 10102367 | 4 | Product used for unknown indication |
| 101023673 | 10102367 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101023673 | 10102367 | HO |
| 101023673 | 10102367 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101023673 | 10102367 | Hypoaesthesia | |
| 101023673 | 10102367 | Macular oedema | |
| 101023673 | 10102367 | Multiple sclerosis relapse | |
| 101023673 | 10102367 | Optic neuritis | |
| 101023673 | 10102367 | Uveitis | |
| 101023673 | 10102367 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101023673 | 10102367 | 1 | 20130703 | 20131106 | 0 | |
| 101023673 | 10102367 | 2 | 20140110 | 0 |